EU Biosimilar Filings, Opinions & Approvals

New biosimilar product filings for review by the European Medicines Agency’s human medicines committee (the CHMP), CHMP opinions, withdrawals of applications and decisions on biosimilar marketing authorizations by the European Commission. Updated monthly.

Click on any column header to sort by that topic. The search box can be used to filter results.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required